Lupin Ltd
Fundamentals-
1)One of the extremely well managed company in pharma-space which should be a part of our portfolio.
2)Aggressive expansions.
3)Excellent sales/growth/profit figures on YOY basis.
4)Manageable debt.
Technicals-
1)Critical support at 1420
CMP-1461(20th Feb'2017)
1st target-1510(2 months)
Long term target 1700-1800 (8-10 months)
Disclaimer : I am a private trader who is just expressing his views. These are just my opinions and i am not giving any kind of free or paid calls. I am using this platform to share my knowledge and learn from other's knowledge. I might be/might not be invested in my opinions.
Note : Please like/comment to show your support.
1)One of the extremely well managed company in pharma-space which should be a part of our portfolio.
2)Aggressive expansions.
3)Excellent sales/growth/profit figures on YOY basis.
4)Manageable debt.
Technicals-
1)Critical support at 1420
CMP-1461(20th Feb'2017)
1st target-1510(2 months)
Long term target 1700-1800 (8-10 months)
Disclaimer : I am a private trader who is just expressing his views. These are just my opinions and i am not giving any kind of free or paid calls. I am using this platform to share my knowledge and learn from other's knowledge. I might be/might not be invested in my opinions.
Note : Please like/comment to show your support.
Transaction en cours
Pharmeceutical sector is going through lots of USFDA downgrades but the earnings and profit of this large cap bluechip are still intact.My opinion is a BUY for long term and this stock can be accumulated for gains.
Targets intact for 12 months.
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.